Life AI Net
홈
아카이브
계산기
디렉토리
뉴스레터
로그인
한국어
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
홈
아카이브
계산기
디렉토리
뉴스레터
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
로그인
홈
아카이브
계산기
디렉토리
More
실시간
10x Genomics Blog
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics Blog
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Yahoo Finance UK
FierceBiotech
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Endpoints News
AbbVie faces questions about Skyrizi competition from J&J
Endpoints News
FDA, AstraZeneca prep for oncology adcomm
Agilent
PCR Plate Sealer Market Leading Players Analysis - Agilent - openPR.com
Thermo Fisher
Leading biotech company launches its first US drug processing hub in Mass. - MassLive
10x Genomics News
Why 10x Genomics Stock Is Sinking Today - TipRanks
Lonza News
Lonza Capsugel donates $50,000 to Project Hope Foundation - Index-Journal
FierceBiotech
AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial
FierceBiotech
Rising costs push GE HealthCare to cut outlook as it restructures units and leadership
FierceBiotech
Teva inks $700M Emalex buyout to bag near-approval Tourette drug
10x Genomics Blog
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics Blog
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Yahoo Finance UK
FierceBiotech
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Endpoints News
AbbVie faces questions about Skyrizi competition from J&J
Endpoints News
FDA, AstraZeneca prep for oncology adcomm
Agilent
PCR Plate Sealer Market Leading Players Analysis - Agilent - openPR.com
Thermo Fisher
Leading biotech company launches its first US drug processing hub in Mass. - MassLive
10x Genomics News
Why 10x Genomics Stock Is Sinking Today - TipRanks
Lonza News
Lonza Capsugel donates $50,000 to Project Hope Foundation - Index-Journal
FierceBiotech
AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial
FierceBiotech
Rising costs push GE HealthCare to cut outlook as it restructures units and leadership
FierceBiotech
Teva inks $700M Emalex buyout to bag near-approval Tourette drug
아카이브
BioWorld
2026년 4월 29일
In the clinic for April 29, 2026
In the clinic for April 29, 2026
원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.